Get startedLog in
    Picture of Notable Labs logo

    NTBLQ — Notable Labs News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: VBL Therapeutics Reports Third Quarter 2020 Financial Results And Provides Corporate Update

    Picture of Notable Labs logoNotable Labs
    16/11/2020 12:13
    Nov 16 (Reuters) - Vascular Biogenics Ltd  VBLT.O :
    * VBL THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * VASCULAR BIOGENICS LTD - EXPECTS CASH, CASH EQUIVALENTS
AMONG
OTHERS TO BE SUFFICIENT TO FUND OPERATING EXPENSES AND CAPEX
NEEDS INTO Q3 OF 2022
    * VASCULAR BIOGENICS LTD QTRLY REVENUES WERE $193 THOUSAND
VERSUS
$79 THOUSAND
    * VASCULAR BIOGENICS LTD QTRLY LOSS PER ORDINARY SHARE $0.12
    * VASCULAR BIOGENICS LTD - INVESTIGATOR SPONSORED VB-111
PHASE 2
STUDIES, IN RGBM IS ON TRACK FOR INITIATION

Source text for Eikon:  ID:nGNX8DL59C 
Further company coverage:  VBLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Notable Labs

    See all news